Update from ASH: What's New in PNH Treatment for 2012?

Presented by: 
Carlos De Castro, III, MD
Presented at: 
American Society of Hematology Annual Meeting 2011
Date of Presentation: 
12/10/2011

Dr. Carlos de Castro of Duke University noted two important findings reported at ASH on pediatric PNH. Researchers comparing clinical characteristics of pediatric PNH patients compared to adult PNH patients found no significant differences. Also, data shared at ASH will likely lead to the approved use of eculuzimab for pediatric patients in the future.